Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Capricor Therapeutics (CAPR) Interest Coverage Ratio: 2011-2017

Historic Interest Coverage Ratio for Capricor Therapeutics (CAPR) over the last 5 years, with Dec 2017 value amounting to -40.85.

  • Capricor Therapeutics' Interest Coverage Ratio fell 44.29% to -40.85 in Q4 2017 from the same period last year, while for Dec 2017 it was -32.25, marking a year-over-year increase of 34.52%. This contributed to the annual value of -32.25 for FY2017, which is 34.52% up from last year.
  • Capricor Therapeutics' Interest Coverage Ratio amounted to -40.85 in Q4 2017, which was down 66.71% from -24.50 recorded in Q3 2017.
  • In the past 5 years, Capricor Therapeutics' Interest Coverage Ratio registered a high of -24.50 during Q3 2017, and its lowest value of -385.96 during Q1 2013.
  • Over the past 3 years, Capricor Therapeutics' median Interest Coverage Ratio value was -47.93 (recorded in 2015), while the average stood at -44.93.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first plummeted by 566.40% in 2013, then soared by 89.59% in 2014.
  • Quarterly analysis of 5 years shows Capricor Therapeutics' Interest Coverage Ratio stood at -245.51 in 2013, then spiked by 61.37% to -24.71 in 2014, then tumbled by 87.00% to -51.66 in 2015, then spiked by 45.20% to -28.31 in 2016, then crashed by 44.29% to -40.85 in 2017.
  • Its Interest Coverage Ratio stands at -40.85 for Q4 2017, versus -24.50 for Q3 2017 and -32.02 for Q2 2017.